Financial Ratios

NURECA LTD.

NSE : NURECABSE : 543264ISIN CODE : INE0DSF01015Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE260.955.95 (+2.33 %)
PREV CLOSE ( ) 255.00
OPEN PRICE ( ) 257.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1262
TODAY'S LOW / HIGH ( )251.40 265.00
52 WK LOW / HIGH ( )200.1 343.6
NSE261.426.51 (+2.55 %)
PREV CLOSE( ) 254.91
OPEN PRICE ( ) 254.78
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12060
TODAY'S LOW / HIGH( ) 252.01 265.00
52 WK LOW / HIGH ( )204 343
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.67-2.44-8.4245.3146.53
   CEPS(Rs)1.49-0.20-6.1246.7446.94
   DPS(Rs)0.000.000.003.002.00
   Book NAV/Share(Rs)192.48192.86195.26203.74163.29
   Tax Rate(%)-45.2225.3023.1426.1225.54
Margin Ratios
   Core EBITDA Margin(%)-7.88-10.87-13.1420.6527.44
   EBIT Margin(%)0.52-2.74-8.9822.9728.51
   Pre Tax Margin(%)-0.36-3.19-9.3522.7027.80
   PAT Margin (%)-0.53-2.38-7.1916.7720.70
   Cash Profit Margin (%)1.17-0.20-5.2217.3020.88
Performance Ratios
   ROA(%)-0.33-1.21-3.6920.0139.73
   ROE(%)-0.35-1.26-4.2224.6952.50
   ROCE(%)0.34-1.45-5.2633.6167.74
   Asset Turnover(x)0.630.510.511.191.92
   Sales/Fixed Asset(x)11.6410.7911.0236.1395.73
   Working Capital/Sales(x)0.730.570.671.401.39
Efficiency Ratios
   Fixed Capital/Sales(x)0.090.090.090.030.01
   Receivable days9.1110.8211.122.0910.65
   Inventory Days92.43109.58149.5367.5243.19
   Payable days24.2026.8122.7118.5226.84
Valuation Parameters
   PER(x)0.000.000.0030.0712.94
   PCE(x)141.65-1275.75-49.0729.1512.83
   Price/Book(x)1.091.321.546.693.69
   Yield(%)0.000.000.000.220.33
   EV/Net Sales(x)1.452.232.055.012.24
   EV/Core EBITDA(x)59.00-370.99-27.9020.157.39
   EV/EBIT(x)252.94-74.88-21.8020.617.44
   EV/CE(x)0.851.091.186.252.90
   M Cap / Sales1.832.702.685.332.82
Growth Ratio
   Net Sales Growth(%)21.29-15.53-56.2119.79114.56
   Core EBITDA Growth(%)595.2493.11-112.95-1.56560.38
   EBIT Growth(%)123.3273.31-116.96-3.17582.32
   PAT Growth(%)72.6571.00-118.59-2.63625.96
   EPS Growth(%)72.6571.00-118.59-2.63-99.27
Financial Stability Ratios
   Total Debt/Equity(x)0.010.000.000.010.01
   Current Ratio(x)17.6620.4521.355.295.78
   Quick Ratio(x)14.2517.3517.543.894.69
   Interest Cover(x)0.59-6.11-24.4284.9040.13
   Total Debt/Mcap(x)0.010.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.